Tonix Pharmaceuticals Holding Corp (LTS:0A4T)
$ 134.6 0 (0%) Market Cap: 17.80 Mil Enterprise Value: 12.04 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 31/100

Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript

Apr 22, 2020 / 04:00PM GMT
Unidentified Participant

Greetings, and welcome to the Tonix Pharmaceuticals Planet MicroCap webcast. It is now my pleasure to introduce your host, CEO, Seth Lederman. Thank you, Mr. Lederman, you may begin.

Seth Lederman
Tonix Pharmaceuticals Holding Corp. - Co-Founder, CEO & Chairman

Thank you very much for the introduction and thank everyone who's participating in watching the webcast and sending in Q&A for your interest in Tonix and our story. I'm Seth Lederman CEO of Tonix and I'll give you an update on our story today.

This is our standard safe harbor disclosure, and we will be making forward-looking statements. We are a publicly listed company and I refer you to our 10-K for more complete information about the company.

These are our two lead programs on slide 3. The first, with a lot of interest already in the Q&A room, is our vaccine to protect against COVID-19. This is in the pre-clinical stage of development. It's a live virus vaccine, and it's designed on our horsepox vaccine platform to express the CoV-2 to spike protein. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot